Menno Kiel
Bis 2023, Global Medical Director, Hematology, F. Hoffman La Roche AG
Zürich, Schweiz
Über mich
Confident communicator with an analytical mindset and a well-developed moral compass, passionate about bringing innovative treatments to patients in need from all over the world. Uniquely skilled as physician and health economist who can leverage both his medical expertise and his knowledge on health technology assessment, outcomes research, health law, regulatory affairs and market access. Has 6+ years of medical affairs experience at the country, regional and global level; 7+ years of clinical scientific experience, and 9+ years of university-level medical education experience. Humanist, pragmatist, and sympathetic yet efficient organizer.
Werdegang
Berufserfahrung von Menno Kiel
3 Jahre und 1 Monat, Juli 2020 - Juli 2023
Global Medical Director, Hematology
F. Hoffman La Roche AG
Medical Lead, Pre-Approval Access / Compassionate Use Programs of the CD20xCD3 bispecifics glofitamab (Columvi) and mosunetuzumab (Lunsumio). Single PoC for senior leadership, drug safety, clinical science, logistics & supply and country affiliates.
Global daily medical management of the “A DUE” clinical trial (NCT03904693) on the effects of a fixed-dose combination of macitentan & tadalafil in pulmonary arterial hypertension (PAH).
6 Monate, Dez. 2018 - Mai 2019
Regional Medical Advisor
Janssen-Cilag GmbH, Johnson & Johnson
Medical Advisor for ibrutinib (Imbruvica) and daratumumab (Darzalex) for the Dutch language area of the Benelux
1 Jahr, Okt. 2017 - Sep. 2018
Country Medical Advisor
AstraZeneca Pharmaceuticals, The Netherlands
Local medical expert for AZ's women’s cancer products: olaparib (Lynparza), fulvestrant (Faslodex), goserelin (Zoladex) and anastrozole (Arimidex)
9 Jahre und 8 Monate, Dez. 2007 - Juli 2017
Program Director & Senior Medical Lecturer
Rotterdam University of Applied Sciences
Daily leadership of the physician assistant master program (MPA), medical teaching responsibilities.
8 Jahre, Jan. 2009 - Dez. 2016
Clinical Scientist & Trial Physician
Erasmus University Medical Center
Co-leadership & daily management of the AIRFORCE-trial: NTR-NL25370.078.09, an academic phase III multi-center RCT on the costs & effects of subcutaneous allergen immunotherapy in adult allergic rhinitis.
1 Jahr, Nov. 2006 - Okt. 2007
Junior Resident Physician Obstetrics & Gynecology
Zaans Medical Centrum
Tending to the medical needs of pregnant and non-pregnant women at the departments of obstetrics, gynecology & fertility medicine.
Ausbildung von Menno Kiel
3 Jahre, Sep. 2008 - Aug. 2011
Health Economics, Policy & Law (HEPL)
Erasmus University Rotterdam
6 Jahre und 11 Monate, Sep. 1999 - Juli 2006
Human medicine
University of Amsterdam
Sprachen
Niederländisch
Muttersprache
Englisch
Fließend
Deutsch
Gut
Französisch
Grundlagen